Earnings History Data for 4D Molecular Therapeutics, Inc. (FDMT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics Inc. is a clinical-stage gene therapy company which develops product candidates using its targeted and evolved adeno-associated viruses vectors. It offers a portfolio of gene therapy product candidates focusing on the ophthalmology, cardiology and pulmonology therapeutic areas. 4D Molecular Therapeutics Inc. is based in Emeryville, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
28-03-2022 AH FDMT 4D Molecular Therapeutics 531.00 -0.85 -0.82 0.00 4D Molecular Therapeutics GAAP EPS of -$2.57, revenue of $18.03M
[3/28/2022 4:38 PM]
16.19 0.78 
(5.06%)
15.41 0.0 
(0.00%)
12.84 - 44.03 183,869 160,000 731
10-11-2021 AH FDMT 4D Molecular Therapeutics 673.00 -0.82 -0.83 0.00 4D Molecular Therapeutics EPS beats by $0.01
[11/10/2021 4:41 PM]
24.78 0.06 
(0.23%)
24.72 0.0 
(0.00%)
21.40 - 55.11 162,661 500,000 1,301